Earnings

UiPath Stock Set for Test After Earnings as AI Concerns Linger

UiPath shares rose 7.23% last week after Q1 revenue beat, but the stock remains down 28.49% year-to-date as AI uncertainty persists.

James Calloway · · · 2 min read · 2 views
UiPath Stock Set for Test After Earnings as AI Concerns Linger
Mentioned in this article
PATH $11.72 +1.21%

UiPath Inc. (NYSE: PATH) heads into Monday trading with a more favorable position after shares climbed during the previous week, supported by better-than-expected quarterly revenue and indications that customers are moving some AI-powered automation projects beyond the testing phase. The stock closed Friday at $11.72, up 1.21% on the day and 7.23% for the week, though it remains down 28.49% since the start of the year.

The company reported fiscal first-quarter revenue of $418 million, a 17% increase year-over-year, surpassing the $397.2 million consensus estimate compiled by Investing.com. Annualized renewal run-rate (ARR), a key subscription metric, rose 12% to $1.901 billion. Dollar-based net retention stood at 109%, indicating that existing customers increased their spending after accounting for churn and downgrades. However, adjusted earnings per share came in at $0.15, missing the $0.16 forecast by a penny.

UiPath also posted GAAP operating income of $28 million for the quarter, reflecting what CFO Ashim Gupta described as "operational discipline" during the earnings call. The company guided for second-quarter revenue between $395 million and $400 million, and for fiscal 2027, it expects revenue in the range of $1.776 billion to $1.781 billion, with ARR projected at $2.058 billion to $2.063 billion.

Analysts reacted positively to the results. RBC Capital Markets highlighted ongoing momentum in AI-related deals and improved customer retention, while Bank of America raised its price target on the stock to $13 from $12. The company is scheduled to present at the William Blair 46th Annual Growth Stock Conference in Chicago on June 2, where investors will be looking for further clarity on AI deal quality and the pace of pilot-to-production conversions.

CEO Daniel Dines emphasized during the earnings call that the company's agentic products—AI tools designed to handle tasks across software applications—are transitioning from pilots to full production. He also dismissed concerns that AI agents would replace UiPath's traditional robotic process automation (RPA) tools, arguing that deterministic bots remain essential for reliability, audit trails, and cost savings. Dines noted that these bots can reduce implementation time from weeks to hours.

Despite the upbeat tone, challenges remain. UiPath's annual filing warns that the automation market is becoming increasingly competitive, with large enterprise vendors, AI startups, and integration firms all developing or acquiring automation capabilities. Competitors such as Automation Anywhere's Agentic Process Automation System and Microsoft's Power Automate are cited by Gartner Peer Insights as alternatives to UiPath's platform. Additionally, CFO Gupta noted weaker contributions from smaller customers and personal productivity use cases, suggesting some segments are lagging.

The broader market provided a supportive backdrop on Friday, with the S&P 500 rising 0.22%, the Nasdaq gaining 0.20%, and the Dow Jones Industrial Average adding 0.72%. UiPath's performance this week will be closely watched as investors assess whether the recent rally is sustainable or merely a relief bounce for a stock that has faced persistent headwinds from AI disruption fears.

This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Market data may be delayed. Always conduct your own research and consult a licensed financial advisor before making investment decisions.

Related Articles

View All →